Drugs / leucoselect phytosome
last change Mar 2025 re-read 3 minutes ago

leucoselect phytosome

Developed for
lung cancer
Investigated by
VA Office of Research and Development

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04515004 Nov 2023 → Nov 2024 lung cancer VA Office of Research and Development Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as leucoselect phytosome ClinicalTrials.gov intervention name — accepted as the source's own label NCT04515004 ↗
Route Oral “taken by mouth once a day” NCT04515004 ↗